𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Oral mucosal non-Hodgkin's lymphoma – a dangerous mimic

✍ Scribed by A. Richards; M.A. Costelloe; J.W. Eveson; C. Scully; G.H. Irvine; N. Rooney


Book ID
114393679
Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
333 KB
Volume
36
Category
Article
ISSN
1368-8375

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Oral idarubicin in non-Hodgkin's lymphom
✍ Massimo Lopez; Luigi Lauro; Paola Papaldo 📂 Article 📅 1986 🏛 Springer US 🌐 English ⚖ 310 KB

Idarubicin (DMDR), a new analogue of daunorubicin, was administered orally once every 3 weeks at the dose of 40 to 45 mg/m 2 to 20 evaluable patients with non-Hodgkin's lymphomas (NHL). Eighty-six percent of patients with favorable histology and 54% with unfavorable histology (intermediate and high